Related Experiment Video
Updated: Nov 2, 2025

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis
Anna G W Rosenberg1,2, Caroline G B Passone3,4, Karlijn Pellikaan1,2
1Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Centre Rotterdam, 3015 GD Rotterdam, the Netherlands.
Insights
Growth hormone treatment (GHt) is safe for adults with Prader-Willi syndrome (PWS), improving body composition. This may help reduce cardiovascular risks in this population.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Disorders
Background:
- Prader-Willi syndrome (PWS) shares features with growth hormone (GH) deficiency, including short stature and altered body composition.
- GH treatment (GHt) is standard for PWS children, improving health and cognition, but its role in adults is less established.
Purpose of the Study:
- To review current knowledge on the efficacy and safety of GH treatment in adults with Prader-Willi syndrome.
Main Methods:
- A systematic literature search was conducted across Medline, Embase, and Cochrane Central Register.
- Included studies were randomized clinical trials (RCTs) and nonrandomized controlled trials (NRCTs) of adults with PWS receiving GHt for ≥6 months.
- Data extracted included body composition, BMI, cardiovascular markers, bone density, cognition, quality of life, and safety.
Main Results:
- Nine RCTs and 20 NRCTs were analyzed. GHt over 12 months significantly improved body composition, increasing lean body mass and reducing fat mass.
- No significant changes were observed in BMI, cholesterol, fasting glucose, or bone mineral density.
- No major safety concerns were reported with GHt in PWS adults.
Conclusions:
- GH treatment appears safe and beneficial for improving body composition in adults with Prader-Willi syndrome.
- Enhanced body composition may potentially lower the high incidence of cardiovascular morbidity associated with PWS.
- Further research may solidify GHt as a therapeutic option for adults with PWS.
Context:
Features of Prader-Willi syndrome (PWS) overlap with features of growth hormone (GH) deficiency, like small hands and feet, short stature, increased body fat, and low muscle mass and strength. In children with PWS, GH treatment (GHt) improves physical health and cognition. GHt has become the standard of care in PWS children, but in adults this is not yet the case.
Objective:
This work aims to provide an overview of the current knowledge on GHt in PWS adults.
Methods:
Medline, Embase, and the Cochrane Central Register of Controlled Trials databases were searched. Study selection included randomized clinical trials (RCTs) and nonrandomized (un)controlled trials (NRCTs) that reported data for adults with PWS, who received GHt for at least 6 months. Data on body composition, body mass index (BMI), cardiovascular end points, bone, cognitive function, quality of life, and safety were extracted.
Results:
Nine RCTs and 20 NRCTs were included. Body composition improved during 12 months of GHt with an increase in mean (95% CI) lean body mass of 1.95 kg (0.04 to 3.87 kg) and a reduction of mean (95% CI) fat mass of -2.23% (-4.10% to -0.36%). BMI, low-density lipoprotein cholesterol levels, fasting glucose levels, and bone mineral density did not change during GHt. There were no major safety issues.
Conclusion:
GHt appears to be safe and improves body composition in adults with PWS. Because poor body composition is closely linked to the observed high incidence of cardiovascular morbidity in adults with PWS, improving body composition might reduce cardiovascular complications in this vulnerable patient group.
Related Concept Videos
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Nature and Nurture
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...

